data_2n7f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n7f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.489 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CZ2' HG23 ' A' ' 32' ' ' VAL . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p . . . . . 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.527 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 HD21 ' HD2' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 10' ' ' CYS . 28.7 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.432 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 52.9 t . . . . . 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 p . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 120.851 0.358 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.581 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 C--O 1.24 0.589 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HE2' ' HE1' ' A' ' 7' ' ' TRP . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.481 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HE2' ' HE1' ' A' ' 7' ' ' TRP . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 m . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.9 m . . . . . 0 CA--C 1.501 -0.91 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m . . . . . 0 CA--C 1.5 -0.959 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.416 -2.174 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.406 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.459 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.415 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.444 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.246 0.884 0 CA-C-O 121.136 0.493 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 120.914 0.388 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.404 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 120.634 0.254 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 32' ' ' VAL . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.404 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 CA--C 1.494 -1.186 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.07 73.5 9.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.014 0.912 . . . . 0.0 109.612 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.39 179.5 3.37 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.581 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.489 ' OE1' ' HB2' ' A' ' 8' ' ' GLU . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.418 ' CZ2' HG23 ' A' ' 32' ' ' VAL . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.489 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t 60.76 94.36 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.7 pt -99.19 161.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.547 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -61.16 149.89 80.92 Favored Pre-proline 0 C--O 1.245 0.848 0 O-C-N 123.599 0.562 . . . . 0.0 111.959 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.4 106.59 0.87 Allowed 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.585 2.19 . . . . 0.0 112.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.0 pt -127.51 -175.97 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.9 119.61 18.35 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.795 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.11 36.01 79.37 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -75.77 170.93 15.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.504 0.652 . . . . 0.0 110.222 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -103.51 128.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -109.46 163.16 13.68 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p -87.1 146.98 25.86 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 HG23 ' CZ2' ' A' ' 7' ' ' TRP . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 CA--C 1.509 -0.624 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.61 110.08 5.25 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.82 169.52 23.41 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.317 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.527 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t 72.38 0.51 3.62 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.73 149.75 4.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -130.17 83.09 64.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.47 -14.56 1.63 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.021 1.814 . . . . 0.0 112.032 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.7 mt -138.24 141.59 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.56 134.52 53.52 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.09 -7.23 10.03 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -98.18 146.38 25.66 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.03 158.92 23.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.894 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -65.69 150.38 48.58 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.9 p -66.11 157.48 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD21 ' HD2' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -116.0 80.79 1.5 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.859 0.838 . . . . 0.0 109.13 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p -176.79 174.14 1.83 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.5 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.456 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 74.5 mt -100.39 132.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -107.62 95.71 14.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 2.9 Cg_exo -78.12 -28.46 4.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.622 2.214 . . . . 0.0 112.706 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 66.5 mt -141.57 142.38 28.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -59.41 120.39 9.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.276 0.489 . . . . 0.0 110.124 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.53 -5.66 64.87 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.439 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.418 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 91.0 t80 -126.32 133.08 51.48 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 26' ' ' CYS . 35.6 m -122.05 147.2 26.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -104.42 106.2 16.61 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.046 0.927 . . . . 0.0 109.611 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.411 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m -149.1 -179.9 7.38 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.24 86.54 5.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.939 0.876 . . . . 0.0 109.73 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.17 179.9 6.63 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.445 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' NE2' ' HA ' ' A' ' 10' ' ' CYS . 28.7 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.432 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.471 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 52.9 t 67.33 -82.34 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.64 144.43 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 14' ' ' ILE . 31.4 m -127.09 158.47 68.9 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -4.28 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.648 2.232 . . . . 0.0 112.849 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 12' ' ' VAL . 48.9 mm -108.97 143.72 18.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.15 142.92 58.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.39 3.0 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.349 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -81.55 164.34 22.0 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.936 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.26 146.44 11.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -89.3 144.58 25.98 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 24' ' ' LEU . 25.2 p -79.85 161.99 25.3 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.358 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -111.3 131.05 55.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p -133.68 174.06 10.85 Favored 'General case' 0 C--N 1.269 -2.933 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.235 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t 68.39 -74.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-O 121.169 0.509 . . . . 0.0 110.095 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.23 156.62 35.24 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.386 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.03 3.54 7.33 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.55 2.167 . . . . 0.0 112.595 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -123.08 178.48 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.28 173.81 7.93 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.492 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 36.19 8.81 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -54.01 133.62 43.51 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.69 0.757 . . . . 0.0 112.928 -175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.49 143.85 15.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.43 150.35 36.57 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 120.922 0.392 . . . . 0.0 110.795 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 62.4 m -71.02 150.69 45.36 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -89.94 96.56 10.73 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p -116.93 179.39 4.03 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.239 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.581 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t 62.5 31.37 17.06 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.2 pt -105.46 163.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.734 -0.603 . . . . 0.0 110.924 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 p -132.09 87.78 42.88 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-O 121.678 0.752 . . . . 0.0 109.687 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.48 -41.94 5.84 Favored 'Trans proline' 0 CA--C 1.519 -0.245 0 C-N-CA 122.735 2.29 . . . . 0.0 112.276 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 pt -138.8 166.68 22.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.1 145.48 42.23 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.64 14.26 60.02 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -88.96 176.08 7.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -103.0 150.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.814 0.816 . . . . 0.0 111.392 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.63 163.65 15.49 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.293 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.9 m -66.01 142.29 57.88 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 CA--C 1.489 -1.403 0 CA-C-O 121.082 0.468 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.05 106.36 18.68 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p -172.33 176.7 3.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HE2' ' HE1' ' A' ' 7' ' ' TRP . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.481 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t 52.68 59.68 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.3 139.53 26.92 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.05 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -66.94 -38.49 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.591 2.194 . . . . 0.0 111.612 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.43 119.35 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.07 137.06 50.89 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -6.63 37.19 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.76 156.4 37.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -112.95 129.53 68.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -120.27 106.53 11.99 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.301 0.572 . . . . 0.0 111.27 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 14.4 p -162.75 168.55 21.33 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.732 0.301 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -91.7 106.49 18.52 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p -114.16 171.53 7.55 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HE2' ' HE1' ' A' ' 7' ' ' TRP . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.5 t 68.55 -71.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.35 148.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.24 143.87 15.78 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.32 61.61 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.058 2.506 . . . . 0.0 113.498 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.0 mt -137.62 122.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -75.08 138.03 41.85 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.752 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.31 31.55 27.75 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.139 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -82.91 174.23 11.1 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.7 -0.294 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.81 140.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -107.62 161.72 14.61 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.6 m -65.97 151.77 46.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.28 107.62 17.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.407 0.622 . . . . 0.0 109.746 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -154.85 175.0 14.31 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.458 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.21 108.25 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.1 pt -115.15 157.78 15.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.789 -0.569 . . . . 0.0 110.357 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.55 92.86 48.33 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 110.822 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.07 -32.88 83.74 Favored 'Trans proline' 0 C--O 1.224 -0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 110.91 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 44.4 mm -132.69 142.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.15 120.52 14.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.101 0.477 . . . . 0.0 109.721 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.05 2.72 59.24 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 82.4 t80 -125.26 114.15 18.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.8 131.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -94.12 106.3 18.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.878 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 93.9 m -159.77 170.67 21.01 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.817 0.342 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.75 95.41 10.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p -118.29 179.42 4.11 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.264 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t 72.86 143.6 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -111.94 132.23 61.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.45 97.22 14.68 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.501 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -64.95 -49.19 3.03 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.739 2.292 . . . . 0.0 110.699 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.44 150.95 27.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.7 130.65 43.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.75 2.29 55.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -111.77 125.75 54.33 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.58 129.65 58.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 123.414 0.446 . . . . 0.0 110.327 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -130.59 105.73 8.03 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m -163.06 -177.12 5.24 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 . . . . . 0 CA--C 1.482 -1.637 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.77 136.17 53.17 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.18 173.31 11.69 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.614 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t 68.49 -78.63 0.04 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -96.7 132.05 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.63 127.23 53.29 Favored Pre-proline 0 C--N 1.287 -2.147 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.41 -6.6 12.78 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.356 2.037 . . . . 0.0 110.451 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.9 mt -110.22 123.15 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.21 145.96 41.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.69 6.55 40.6 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.462 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -114.43 175.31 5.54 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 122.685 0.394 . . . . 0.0 109.969 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.61 -178.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.808 0.813 . . . . 0.0 112.842 -176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -96.04 164.59 12.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.393 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p -65.26 141.56 58.58 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 CA--C 1.494 -1.201 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.65 79.48 8.22 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.583 0.706 . . . . 0.0 109.618 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p -143.42 171.7 13.78 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.875 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.406 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t 79.46 143.37 0.08 Allowed 'General case' 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 19' ' ' TYR . 67.4 mt -125.1 132.15 71.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.31 99.75 30.39 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.486 ' HD2' ' O ' ' A' ' 17' ' ' PHE . 35.7 Cg_endo -67.15 -52.97 0.54 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.321 2.014 . . . . 0.0 111.841 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.23 141.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.02 120.64 6.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.679 0.752 . . . . 0.0 111.725 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.38 -6.46 36.33 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.198 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 98.5 m-85 -126.75 125.97 42.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.86 146.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 32.4 m-85 -106.27 105.17 15.08 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.738 0.78 . . . . 0.0 110.56 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.427 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m -162.55 173.31 14.14 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 121.25 0.547 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 29.4 t70 -90.5 -135.29 0.12 Allowed 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.463 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 24.9 p -113.43 175.27 5.52 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.415 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.76 -73.67 0.09 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.46 131.15 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -135.87 119.4 12.65 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.93 19.16 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 pt -99.79 161.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.8 tp -75.01 122.76 24.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.47 35.75 1.54 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.01 131.93 41.46 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 111.244 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.14 141.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.34 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.24 144.64 29.02 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p -80.55 144.72 32.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.958 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.415 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -117.43 100.74 7.87 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -98.64 170.92 8.46 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.444 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t 71.99 -78.56 0.05 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.9 132.54 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.09 124.59 26.46 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.37 -19.12 43.95 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.675 2.25 . . . . 0.0 112.919 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -110.98 144.38 19.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.816 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.28 171.96 13.66 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.77 5.01 57.77 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.83 175.04 8.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.817 1.247 . . . . 0.0 108.116 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.89 169.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.22 164.81 13.1 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.158 0.583 . . . . 0.0 109.527 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p -64.35 150.51 46.09 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.784 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.16 109.07 20.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.83 179.28 7.96 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.044 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.402 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t 70.99 -2.53 2.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 35.7 pt -96.45 179.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 110.137 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.82 92.96 26.91 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 8.2 Cg_exo -77.31 -40.08 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.481 2.12 . . . . 0.0 110.574 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -148.16 164.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.16 169.95 17.1 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.365 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.31 34.93 69.23 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -87.65 170.48 11.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.645 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.55 145.7 14.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -109.67 163.53 13.39 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.8 p -73.98 145.17 44.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.689 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? . . . . . 0 CA--C 1.496 -1.119 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.46 81.67 8.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.132 0.968 . . . . 0.0 111.907 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p -146.27 174.76 11.05 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 40.3 t 74.41 -0.91 3.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.34 132.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.549 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -115.49 169.44 6.84 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.85 35.49 0.26 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.258 2.639 . . . . 0.0 114.86 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.78 125.03 51.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 129.39 37.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.82 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.54 -6.77 79.15 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.013 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -127.93 109.77 11.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.599 ' HB ' ' O ' ' A' ' 10' ' ' CYS . 27.7 m -125.1 129.35 73.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -137.33 163.0 32.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p -142.43 -175.06 4.31 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 . . . . . 0 N--CA 1.441 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.44 102.3 14.76 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.294 0.569 . . . . 0.0 109.885 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p -132.11 166.29 22.12 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.977 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.404 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t 58.22 93.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.38 136.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.592 -172.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 18' ' ' VAL . 14.1 m -129.67 83.72 63.57 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 112.298 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.444 ' HD2' ' CE1' ' A' ' 19' ' ' TYR . 20.8 Cg_exo -71.6 -43.31 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.306 2.004 . . . . 0.0 110.479 175.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -105.21 123.05 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.38 128.9 38.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.152 0.501 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 -6.54 35.53 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.431 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.92 134.43 50.44 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.432 ' HA ' HG11 ' A' ' 12' ' ' VAL . 21.6 m -106.64 131.22 57.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.444 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 71.5 m-85 -103.94 106.06 16.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.409 1.1 . . . . 0.0 112.39 -175.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 p -163.42 170.97 16.65 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 . . . . . 0 CA--C 1.487 -1.449 0 CA-C-O 120.944 0.402 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -92.58 106.77 18.69 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p -149.15 172.21 15.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.027 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' CD1' ' A' ' 7' ' ' TRP . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.449 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t 57.75 41.66 24.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.02 159.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.06 133.68 10.37 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.545 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.95 -48.34 16.82 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.96 2.44 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.75 129.55 74.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.46 151.61 45.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.729 0.3 . . . . 0.0 110.672 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.47 -5.23 54.76 Favored Glycine 0 C--N 1.313 -0.736 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -126.69 148.13 49.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.4 130.16 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.64 118.25 18.92 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m -135.92 178.1 7.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.22 121.7 42.76 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p -65.82 154.56 38.8 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.431 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t 69.15 108.85 0.05 Allowed 'General case' 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 19' ' ' TYR . 10.1 tt -110.84 138.54 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.99 90.49 28.22 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.4 0.619 . . . . 0.0 110.426 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.61 -41.12 11.95 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.632 2.221 . . . . 0.0 111.897 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 47.4 mm -123.54 129.55 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.38 120.68 12.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.588 0.709 . . . . 0.0 110.851 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.05 44.54 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.879 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.74 113.47 16.7 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.05 142.17 18.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.411 ' HB3' HG23 ' A' ' 11' ' ' ILE . 68.2 t80 -102.61 106.46 17.14 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.825 0.821 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m -150.21 177.74 9.64 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -104.61 106.68 17.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p -121.48 169.1 10.98 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.744 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HB2' ' HA ' ' A' ' 32' ' ' VAL . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.404 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t 62.33 21.16 12.34 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -96.31 132.33 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.369 0.604 . . . . 0.0 110.292 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.04 157.52 71.22 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.46 6.3 5.5 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.756 2.304 . . . . 0.0 113.163 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 pt -124.73 119.16 55.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.2 141.68 28.16 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.2 51.28 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.06 132.7 56.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -104.83 139.21 26.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -136.1 107.63 6.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.871 0.367 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m -154.15 -178.75 7.32 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p . . . . . 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 6' ' ' LYS . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.573 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.573 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 21.9 p . . . . . 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 6' ' ' LYS . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.7 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 52.9 t . . . . . 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.2 p . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 6' ' ' LYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 62.4 m . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 120.851 0.358 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 6' ' ' LYS . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.623 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 59.9 m . . . . . 0 C--O 1.24 0.589 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.537 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 14.4 p . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 6' ' ' LYS . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.529 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 26.5 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 43.6 m . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 93.9 m . . . . . 0 CA--C 1.501 -0.91 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.6 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m . . . . . 0 CA--C 1.5 -0.959 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 6' ' ' LYS . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 6' ' ' LYS . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.416 -2.174 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.522 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 24' ' ' LEU . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 30.7 p . . . . . 0 C--O 1.246 0.884 0 CA-C-O 121.136 0.493 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 29.8 p . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 120.914 0.388 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 6' ' ' LYS . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.47 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 20.2 p . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 6' ' ' LYS . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 120.634 0.254 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.439 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 6' ' ' LYS . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 5' ' ' GLU . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 CA--C 1.494 -1.186 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.07 73.5 9.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.014 0.912 . . . . 0.0 109.612 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.39 179.5 3.37 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.581 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t 60.76 94.36 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.7 pt -99.19 161.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.547 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -61.16 149.89 80.92 Favored Pre-proline 0 C--O 1.245 0.848 0 O-C-N 123.599 0.562 . . . . 0.0 111.959 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.4 106.59 0.87 Allowed 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.585 2.19 . . . . 0.0 112.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.0 pt -127.51 -175.97 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.9 119.61 18.35 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.795 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.11 36.01 79.37 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -75.77 170.93 15.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.504 0.652 . . . . 0.0 110.222 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -103.51 128.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -109.46 163.16 13.68 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p -87.1 146.98 25.86 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 6' ' ' LYS . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 CA--C 1.509 -0.624 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.61 110.08 5.25 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.82 169.52 23.41 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.317 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.573 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.573 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t 72.38 0.51 3.62 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.73 149.75 4.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 17' ' ' PHE . 60.2 t -130.17 83.09 64.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.47 -14.56 1.63 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.021 1.814 . . . . 0.0 112.032 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.7 mt -138.24 141.59 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.56 134.52 53.52 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.09 -7.23 10.03 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' A' ' 12' ' ' VAL . 62.3 m-85 -98.18 146.38 25.66 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.03 158.92 23.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.894 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -65.69 150.38 48.58 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 21.9 p -66.11 157.48 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -116.0 80.79 1.5 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.859 0.838 . . . . 0.0 109.13 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p -176.79 174.14 1.83 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.5 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.465 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 74.5 mt -100.39 132.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -107.62 95.71 14.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 2.9 Cg_exo -78.12 -28.46 4.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.622 2.214 . . . . 0.0 112.706 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 66.5 mt -141.57 142.38 28.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -59.41 120.39 9.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.276 0.489 . . . . 0.0 110.124 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.53 -5.66 64.87 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.439 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 91.0 t80 -126.32 133.08 51.48 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 26' ' ' CYS . 35.6 m -122.05 147.2 26.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -104.42 106.2 16.61 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.046 0.927 . . . . 0.0 109.611 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m -149.1 -179.9 7.38 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 6' ' ' LYS . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.24 86.54 5.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.939 0.876 . . . . 0.0 109.73 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.17 179.9 6.63 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.445 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 3.9 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t 67.33 -82.34 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.64 144.43 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 17' ' ' PHE . 31.4 m -127.09 158.47 68.9 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -4.28 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.648 2.232 . . . . 0.0 112.849 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -108.97 143.72 18.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.15 142.92 58.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.39 3.0 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.349 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 12' ' ' VAL . 37.0 p90 -81.55 164.34 22.0 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.26 146.44 11.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -89.3 144.58 25.98 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.2 p -79.85 161.99 25.3 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.358 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 6' ' ' LYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -111.3 131.05 55.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p -133.68 174.06 10.85 Favored 'General case' 0 C--N 1.269 -2.933 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.235 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t 68.39 -74.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -120.55 132.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-O 121.169 0.509 . . . . 0.0 110.095 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.23 156.62 35.24 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.386 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.03 3.54 7.33 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.55 2.167 . . . . 0.0 112.595 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -123.08 178.48 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.28 173.81 7.93 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.492 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 36.19 8.81 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -54.01 133.62 43.51 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.69 0.757 . . . . 0.0 112.928 -175.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.49 143.85 15.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.43 150.35 36.57 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 120.922 0.392 . . . . 0.0 110.795 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 62.4 m -71.02 150.69 45.36 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 6' ' ' LYS . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -89.94 96.56 10.73 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p -116.93 179.39 4.03 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.239 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.623 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t 62.5 31.37 17.06 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.2 pt -105.46 163.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.734 -0.603 . . . . 0.0 110.924 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 p -132.09 87.78 42.88 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-O 121.678 0.752 . . . . 0.0 109.687 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.48 -41.94 5.84 Favored 'Trans proline' 0 CA--C 1.519 -0.245 0 C-N-CA 122.735 2.29 . . . . 0.0 112.276 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 pt -138.8 166.68 22.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.1 145.48 42.23 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.64 14.26 60.02 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -88.96 176.08 7.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -103.0 150.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.814 0.816 . . . . 0.0 111.392 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.63 163.65 15.49 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.293 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 59.9 m -66.01 142.29 57.88 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 CA--C 1.489 -1.403 0 CA-C-O 121.082 0.468 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.05 106.36 18.68 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p -172.33 176.7 3.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.537 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t 52.68 59.68 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.3 139.53 26.92 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.05 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -66.94 -38.49 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.591 2.194 . . . . 0.0 111.612 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.43 119.35 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.07 137.06 50.89 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -6.63 37.19 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.76 156.4 37.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -112.95 129.53 68.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -120.27 106.53 11.99 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.301 0.572 . . . . 0.0 111.27 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 14.4 p -162.75 168.55 21.33 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 6' ' ' LYS . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.732 0.301 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -91.7 106.49 18.52 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p -114.16 171.53 7.55 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.529 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 26.5 t 68.55 -71.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.35 148.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.24 143.87 15.78 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.32 61.61 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.058 2.506 . . . . 0.0 113.498 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.0 mt -137.62 122.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -75.08 138.03 41.85 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.752 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.31 31.55 27.75 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.139 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -82.91 174.23 11.1 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.7 -0.294 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.81 140.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -107.62 161.72 14.61 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 43.6 m -65.97 151.77 46.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.28 107.62 17.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.407 0.622 . . . . 0.0 109.746 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -154.85 175.0 14.31 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.21 108.25 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 19' ' ' TYR . 37.1 pt -115.15 157.78 15.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.789 -0.569 . . . . 0.0 110.357 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.55 92.86 48.33 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 110.822 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.07 -32.88 83.74 Favored 'Trans proline' 0 C--O 1.224 -0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 110.91 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 44.4 mm -132.69 142.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.15 120.52 14.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.101 0.477 . . . . 0.0 109.721 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.05 2.72 59.24 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 82.4 t80 -125.26 114.15 18.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.8 131.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' HB3' HG13 ' A' ' 11' ' ' ILE . 90.6 t80 -94.12 106.3 18.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.878 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 93.9 m -159.77 170.67 21.01 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.6 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.817 0.342 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.75 95.41 10.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p -118.29 179.42 4.11 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.264 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 2.4 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t 72.86 143.6 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -111.94 132.23 61.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.45 97.22 14.68 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.501 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -64.95 -49.19 3.03 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.739 2.292 . . . . 0.0 110.699 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.44 150.95 27.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.7 130.65 43.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.75 2.29 55.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -111.77 125.75 54.33 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.58 129.65 58.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 123.414 0.446 . . . . 0.0 110.327 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -130.59 105.73 8.03 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m -163.06 -177.12 5.24 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 6' ' ' LYS . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 . . . . . 0 CA--C 1.482 -1.637 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.77 136.17 53.17 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.18 173.31 11.69 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.614 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t 68.49 -78.63 0.04 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -96.7 132.05 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.63 127.23 53.29 Favored Pre-proline 0 C--N 1.287 -2.147 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.41 -6.6 12.78 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.356 2.037 . . . . 0.0 110.451 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.9 mt -110.22 123.15 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.21 145.96 41.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.69 6.55 40.6 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.462 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -114.43 175.31 5.54 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 122.685 0.394 . . . . 0.0 109.969 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.61 -178.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.808 0.813 . . . . 0.0 112.842 -176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -96.04 164.59 12.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.393 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p -65.26 141.56 58.58 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 6' ' ' LYS . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 CA--C 1.494 -1.201 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.65 79.48 8.22 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.583 0.706 . . . . 0.0 109.618 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p -143.42 171.7 13.78 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.875 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t 79.46 143.37 0.08 Allowed 'General case' 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' TYR . 67.4 mt -125.1 132.15 71.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.31 99.75 30.39 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 17' ' ' PHE . 35.7 Cg_endo -67.15 -52.97 0.54 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.321 2.014 . . . . 0.0 111.841 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.23 141.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.02 120.64 6.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.679 0.752 . . . . 0.0 111.725 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.38 -6.46 36.33 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.198 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 98.5 m-85 -126.75 125.97 42.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.86 146.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 32.4 m-85 -106.27 105.17 15.08 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.738 0.78 . . . . 0.0 110.56 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m -162.55 173.31 14.14 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 121.25 0.547 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 29.4 t70 -90.5 -135.29 0.12 Allowed 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 24.9 p -113.43 175.27 5.52 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 24' ' ' LEU . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.76 -73.67 0.09 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.46 131.15 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 14' ' ' ILE . 12.2 p -135.87 119.4 12.65 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.93 19.16 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 12' ' ' VAL . 27.8 pt -99.79 161.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.8 tp -75.01 122.76 24.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.47 35.75 1.54 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.01 131.93 41.46 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 111.244 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.14 141.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.34 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.24 144.64 29.02 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p -80.55 144.72 32.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.958 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -117.43 100.74 7.87 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -98.64 170.92 8.46 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t 71.99 -78.56 0.05 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.9 132.54 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.09 124.59 26.46 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.37 -19.12 43.95 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.675 2.25 . . . . 0.0 112.919 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -110.98 144.38 19.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.816 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.28 171.96 13.66 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.77 5.01 57.77 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.83 175.04 8.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.817 1.247 . . . . 0.0 108.116 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.89 169.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.22 164.81 13.1 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.158 0.583 . . . . 0.0 109.527 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 30.7 p -64.35 150.51 46.09 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.784 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.16 109.07 20.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.83 179.28 7.96 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.044 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t 70.99 -2.53 2.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 35.7 pt -96.45 179.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 110.137 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.82 92.96 26.91 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 8.2 Cg_exo -77.31 -40.08 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.481 2.12 . . . . 0.0 110.574 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -148.16 164.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.16 169.95 17.1 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.365 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.31 34.93 69.23 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -87.65 170.48 11.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.645 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.55 145.7 14.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -109.67 163.53 13.39 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 29.8 p -73.98 145.17 44.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.689 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? . . . . . 0 CA--C 1.496 -1.119 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.46 81.67 8.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.132 0.968 . . . . 0.0 111.907 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p -146.27 174.76 11.05 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 40.3 t 74.41 -0.91 3.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.34 132.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.549 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -115.49 169.44 6.84 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.85 35.49 0.26 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.258 2.639 . . . . 0.0 114.86 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.78 125.03 51.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 129.39 37.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.82 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.54 -6.77 79.15 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.013 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -127.93 109.77 11.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 10' ' ' CYS . 27.7 m -125.1 129.35 73.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -137.33 163.0 32.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p -142.43 -175.06 4.31 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 6' ' ' LYS . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 . . . . . 0 N--CA 1.441 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.44 102.3 14.76 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.294 0.569 . . . . 0.0 109.885 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p -132.11 166.29 22.12 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.977 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.47 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t 58.22 93.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG13 HE22 ' A' ' 4' ' ' GLN . 67.8 mt -96.38 136.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.592 -172.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 18' ' ' VAL . 14.1 m -129.67 83.72 63.57 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 112.298 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' CE1' ' A' ' 19' ' ' TYR . 20.8 Cg_exo -71.6 -43.31 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.306 2.004 . . . . 0.0 110.479 175.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -105.21 123.05 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.38 128.9 38.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.152 0.501 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 -6.54 35.53 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.431 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.92 134.43 50.44 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 26' ' ' CYS . 21.6 m -106.64 131.22 57.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 71.5 m-85 -103.94 106.06 16.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.409 1.1 . . . . 0.0 112.39 -175.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 20.2 p -163.42 170.97 16.65 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 6' ' ' LYS . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 . . . . . 0 CA--C 1.487 -1.449 0 CA-C-O 120.944 0.402 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -92.58 106.77 18.69 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p -149.15 172.21 15.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.027 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.439 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t 57.75 41.66 24.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.02 159.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.06 133.68 10.37 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.545 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.95 -48.34 16.82 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.96 2.44 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.75 129.55 74.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.46 151.61 45.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.729 0.3 . . . . 0.0 110.672 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.47 -5.23 54.76 Favored Glycine 0 C--N 1.313 -0.736 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -126.69 148.13 49.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.4 130.16 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.64 118.25 18.92 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m -135.92 178.1 7.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.22 121.7 42.76 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p -65.82 154.56 38.8 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t 69.15 108.85 0.05 Allowed 'General case' 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 19' ' ' TYR . 10.1 tt -110.84 138.54 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.99 90.49 28.22 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.4 0.619 . . . . 0.0 110.426 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.61 -41.12 11.95 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.632 2.221 . . . . 0.0 111.897 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 47.4 mm -123.54 129.55 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.38 120.68 12.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.588 0.709 . . . . 0.0 110.851 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.05 44.54 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.879 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 88.5 t80 -126.74 113.47 16.7 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.05 142.17 18.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB3' HG23 ' A' ' 11' ' ' ILE . 68.2 t80 -102.61 106.46 17.14 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.825 0.821 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m -150.21 177.74 9.64 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 6' ' ' LYS . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -104.61 106.68 17.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p -121.48 169.1 10.98 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.744 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 5' ' ' GLU . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t 62.33 21.16 12.34 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -96.31 132.33 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.369 0.604 . . . . 0.0 110.292 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.04 157.52 71.22 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.46 6.3 5.5 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.756 2.304 . . . . 0.0 113.163 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 pt -124.73 119.16 55.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.2 141.68 28.16 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.2 51.28 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.06 132.7 56.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -104.83 139.21 26.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -136.1 107.63 6.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.871 0.367 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m -154.15 -178.75 7.32 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.43 -1.465 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p . . . . . 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 6' ' ' LYS . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p . . . . . 0 N--CA 1.419 -1.993 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.573 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.573 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 21.9 p . . . . . 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p . . . . . 0 N--CA 1.422 -1.863 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 6' ' ' LYS . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.7 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 52.9 t . . . . . 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.2 p . . . . . 0 N--CA 1.426 -1.674 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 6' ' ' LYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.436 -1.162 0 CA-C-O 120.632 0.253 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 62.4 m . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 120.851 0.358 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 6' ' ' LYS . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.623 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 59.9 m . . . . . 0 C--O 1.24 0.589 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.537 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 14.4 p . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 6' ' ' LYS . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.441 -0.898 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.529 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 26.5 t . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 43.6 m . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 93.9 m . . . . . 0 CA--C 1.501 -0.91 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.6 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t . . . . . 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m . . . . . 0 CA--C 1.5 -0.959 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 6' ' ' LYS . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t . . . . . 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p . . . . . 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 6' ' ' LYS . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.416 -2.174 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.522 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m . . . . . 0 N--CA 1.429 -1.492 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 24' ' ' LEU . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t . . . . . 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p . . . . . 0 C--O 1.242 0.663 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t . . . . . 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 30.7 p . . . . . 0 C--O 1.246 0.884 0 CA-C-O 121.136 0.493 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.419 -1.988 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 29.8 p . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 120.914 0.388 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.427 -1.613 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p . . . . . 0 N--CA 1.434 -1.268 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 6' ' ' LYS . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 N--CA 1.425 -1.684 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.47 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 20.2 p . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 6' ' ' LYS . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.437 -1.103 0 CA-C-O 120.634 0.254 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.439 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m . . . . . 0 C--O 1.247 0.957 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 6' ' ' LYS . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.431 -1.395 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 5' ' ' GLU . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 . . . . . 0 CA--C 1.494 -1.186 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.07 73.5 9.84 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 122.014 0.912 . . . . 0.0 109.612 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.3 p -170.39 179.5 3.37 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.581 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 9.4 pt20 -116.23 163.93 15.26 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.93 173.78 3.41 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.465 176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.572 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 37.4 pttt -73.7 -48.1 34.62 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.533 -173.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -83.55 23.08 0.98 Allowed 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 7.9 mm-40 -83.99 -106.14 0.04 OUTLIER 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.438 -175.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -108.74 -60.15 1.78 Allowed 'General case' 0 CA--C 1.487 -1.447 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.293 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.2 t 60.76 94.36 0.04 OUTLIER 'General case' 0 C--O 1.238 0.454 0 O-C-N 124.36 1.038 . . . . 0.0 109.576 -172.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.7 pt -99.19 161.68 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.547 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.4 m -61.16 149.89 80.92 Favored Pre-proline 0 C--O 1.245 0.848 0 O-C-N 123.599 0.562 . . . . 0.0 111.959 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.4 106.59 0.87 Allowed 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.585 2.19 . . . . 0.0 112.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.0 pt -127.51 -175.97 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.9 119.61 18.35 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 120.407 -0.517 . . . . 0.0 109.795 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 69.11 36.01 79.37 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.472 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -75.77 170.93 15.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.504 0.652 . . . . 0.0 110.222 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -103.51 128.92 56.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -109.46 163.16 13.68 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.039 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.4 p -87.1 146.98 25.86 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.8 m -46.02 153.48 0.67 Allowed Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 114.433 1.272 . . . . 0.0 114.433 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.36 144.8 98.6 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.976 2.451 . . . . 0.0 112.352 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.65 7.97 59.84 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.75 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 6' ' ' LYS . 24.0 mt -122.68 154.53 37.94 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -130.09 136.95 57.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 4.2 t -87.29 115.99 25.07 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.02 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.302 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.85 -173.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.98 -39.6 84.43 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.519 2.813 . . . . 0.0 113.778 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.4 t80 173.59 -29.68 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.27 -172.87 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 113.338 -1.756 . . . . 0.0 108.063 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.572 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 89.3 m -82.93 164.03 20.7 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-O 121.383 0.611 . . . . 0.0 109.562 177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.282 -2.33 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.283 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 CA--C 1.509 -0.624 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -70.61 110.08 5.25 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 171.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.1 p -159.82 169.52 23.41 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.317 -177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.6 pt20 -118.99 166.69 12.55 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 -178.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -64.27 166.39 8.1 Favored 'General case' 0 C--N 1.292 -1.919 0 O-C-N 124.532 1.145 . . . . 0.0 112.654 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.573 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 18.6 pttt -76.82 -48.36 18.75 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.872 -174.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.573 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 94.3 m95 -78.78 21.65 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -83.84 179.7 7.5 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.037 0.535 . . . . 0.0 110.048 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -64.78 -26.37 68.32 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.9 t 72.38 0.51 3.62 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.383 1.073 . . . . 0.0 112.893 173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.73 149.75 4.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 113.653 0.982 . . . . 0.0 113.653 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 17' ' ' PHE . 60.2 t -130.17 83.09 64.21 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -91.47 -14.56 1.63 Allowed 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.021 1.814 . . . . 0.0 112.032 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 73.7 mt -138.24 141.59 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.56 134.52 53.52 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.09 -7.23 10.03 Favored Glycine 0 C--N 1.297 -1.59 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.424 ' HB2' HG13 ' A' ' 12' ' ' VAL . 62.3 m-85 -98.18 146.38 25.66 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.03 158.92 23.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.894 -173.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -65.69 150.38 48.58 Favored 'General case' 0 C--O 1.257 1.449 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 21.9 p -66.11 157.48 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.981 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.0 152.18 3.96 Favored Pre-proline 0 C--N 1.305 -1.335 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.531 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.89 139.94 82.44 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.303 2.002 . . . . 0.0 112.174 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.12 -0.97 57.46 Favored Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.55 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' A' ' 6' ' ' LYS . 16.1 mt -112.62 151.62 29.89 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -130.68 137.24 56.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.426 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.5 t -85.59 95.94 9.49 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.5 -85.63 0.33 Allowed Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.567 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.47 -77.62 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.551 1.501 . . . . 0.0 110.999 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -122.78 -19.03 6.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 m -120.77 169.55 11.89 Favored 'Isoleucine or valine' 0 C--O 1.247 0.962 0 CA-C-O 120.853 0.359 . . . . 0.0 110.722 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.6 m -87.2 158.97 19.01 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.7 p . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -116.0 80.79 1.5 Allowed 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.859 0.838 . . . . 0.0 109.13 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.9 p -176.79 174.14 1.83 Allowed 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.5 pt20 -117.58 156.16 28.59 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.64 -175.53 0.39 Allowed 'General case' 0 C--N 1.281 -2.376 0 O-C-N 124.127 0.892 . . . . 0.0 111.459 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.8 ptmt -77.07 -50.66 12.56 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.803 -173.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.5 m95 -83.81 27.11 0.66 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.344 -0.847 . . . . 0.0 111.754 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 11.1 mm-40 -84.3 -150.4 0.12 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -78.03 -30.25 49.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.918 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.7 t 62.5 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.204 1.002 . . . . 0.0 110.979 -176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.465 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 74.5 mt -100.39 132.73 45.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -177.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.3 t -107.62 95.71 14.83 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 2.9 Cg_exo -78.12 -28.46 4.81 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.622 2.214 . . . . 0.0 112.706 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 66.5 mt -141.57 142.38 28.85 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.0 pt? -59.41 120.39 9.26 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 118.276 0.489 . . . . 0.0 110.124 177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.53 -5.66 64.87 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.439 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 91.0 t80 -126.32 133.08 51.48 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 26' ' ' CYS . 35.6 m -122.05 147.2 26.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -104.42 106.2 16.61 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.046 0.927 . . . . 0.0 109.611 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 94.7 m -149.1 -179.9 7.38 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 103.709 -2.701 . . . . 0.0 103.709 175.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.0 m -63.28 150.7 88.7 Favored Pre-proline 0 C--N 1.285 -2.206 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.78 174.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -63.0 143.38 90.91 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.704 2.269 . . . . 0.0 111.975 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.9 7.91 60.9 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.026 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HB3' ' A' ' 6' ' ' LYS . 32.3 mt -117.64 158.11 25.22 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.1 pt -131.76 142.7 42.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 5.3 t -91.46 97.47 11.09 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.94 -84.54 0.4 Allowed Glycine 0 N--CA 1.434 -1.461 0 CA-C-N 114.799 -1.091 . . . . 0.0 112.605 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -74.61 -75.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 121.964 1.776 . . . . 0.0 111.732 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -134.83 -6.55 2.43 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.9 m -132.47 165.98 30.59 Favored 'Isoleucine or valine' 0 C--O 1.248 1.023 0 CA-C-N 115.142 -0.936 . . . . 0.0 109.702 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 84.8 m -76.8 167.09 22.43 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.468 0.652 . . . . 0.0 110.56 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 -172.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -80.24 86.54 5.63 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-O 121.939 0.876 . . . . 0.0 109.73 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -142.17 179.9 6.63 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 114.224 -1.353 . . . . 0.0 108.445 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.7 pt20 -112.08 156.72 21.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -176.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -73.79 -177.33 2.74 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-O 122.068 0.937 . . . . 0.0 113.214 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.586 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 ptmt -72.41 -50.5 25.97 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.245 -1.343 . . . . 0.0 112.819 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.3 m95 -83.96 25.02 0.85 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.453 ' HG3' ' HB2' ' A' ' 4' ' ' GLN . 37.4 mm-40 -84.84 -174.96 5.56 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -61.76 -42.27 98.76 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.437 ' HA ' ' NE2' ' A' ' 4' ' ' GLN . 52.9 t 67.33 -82.34 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.099 0.96 . . . . 0.0 109.259 -173.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.4 mt -100.64 144.43 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 17' ' ' PHE . 31.4 m -127.09 158.47 68.9 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -4.28 15.15 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.648 2.232 . . . . 0.0 112.849 -176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.9 mm -108.97 143.72 18.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.15 142.92 58.24 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.032 0.444 . . . . 0.0 110.916 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.92 35.39 3.0 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.349 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB3' HG22 ' A' ' 12' ' ' VAL . 37.0 p90 -81.55 164.34 22.0 Favored 'General case' 0 C--O 1.248 0.976 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.936 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.26 146.44 11.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -175.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -89.3 144.58 25.98 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.48 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 25.2 p -79.85 161.99 25.3 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.358 178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.7 m -50.22 150.31 4.5 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 124.271 0.982 . . . . 0.0 113.131 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.62 132.53 38.19 Favored 'Trans proline' 0 C--O 1.248 1.004 0 C-N-CA 122.921 2.414 . . . . 0.0 111.647 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.38 4.2 40.75 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 6' ' ' LYS . 27.3 mt -117.22 146.21 43.4 Favored 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 pt -110.85 129.96 65.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.682 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -92.46 88.91 6.55 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.41 -88.06 0.71 Allowed Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 114.61 -1.177 . . . . 0.0 113.689 -172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -61.78 -49.21 7.31 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.73 2.287 . . . . 0.0 112.65 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -172.43 -32.87 0.01 OUTLIER 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -174.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 32.8 m -105.55 174.08 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.934 177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.586 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 97.1 m -90.4 175.61 7.03 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 121.186 0.517 . . . . 0.0 110.13 177.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.285 -2.207 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -172.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -111.3 131.05 55.46 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.4 p -133.68 174.06 10.85 Favored 'General case' 0 C--N 1.269 -2.933 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.235 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.2 pt20 -120.52 162.53 19.43 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -67.75 169.51 9.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.335 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.606 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 ptmt -71.76 -48.52 46.22 Favored 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.699 -175.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -82.74 27.96 0.51 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.299 0.571 . . . . 0.0 112.23 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -84.26 -167.24 1.69 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.414 0.686 . . . . 0.0 109.933 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.4 -19.26 61.03 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.545 0.212 . . . . 0.0 111.356 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.5 t 68.39 -74.79 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.104 0.962 . . . . 0.0 110.954 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -120.55 132.68 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-O 121.169 0.509 . . . . 0.0 110.095 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.23 156.62 35.24 Favored Pre-proline 0 C--N 1.306 -1.286 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.386 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.03 3.54 7.33 Favored 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 122.55 2.167 . . . . 0.0 112.595 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 19.7 pt -123.08 178.48 3.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.28 173.81 7.93 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.492 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 36.19 8.81 Favored Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -54.01 133.62 43.51 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.69 0.757 . . . . 0.0 112.928 -175.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.1 m -104.49 143.85 15.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -115.43 150.35 36.57 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 120.922 0.392 . . . . 0.0 110.795 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.446 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 62.4 m -71.02 150.69 45.36 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 -178.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.8 m -55.63 152.27 19.03 Favored Pre-proline 0 C--N 1.311 -1.089 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.796 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.44 144.13 97.94 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 123.037 2.492 . . . . 0.0 112.497 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.76 4.47 56.92 Favored Glycine 0 C--N 1.304 -1.231 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.883 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.501 HD13 ' HB3' ' A' ' 6' ' ' LYS . 19.2 mt -118.12 159.53 23.1 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.4 pt -130.9 142.24 44.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 10.5 t -98.54 87.1 3.73 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.47 -79.99 0.58 Allowed Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.195 -173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -80.47 -86.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.613 0 C-N-CA 121.777 1.652 . . . . 0.0 112.003 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -114.5 -21.59 10.24 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.012 0.435 . . . . 0.0 110.198 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.87 176.99 6.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.341 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.5 m -87.02 168.93 12.87 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 C--N 1.283 -2.3 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -174.369 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 . . . . . 0 N--CA 1.44 -0.965 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -89.94 96.56 10.73 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.5 p -116.93 179.39 4.03 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.239 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.403 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -117.74 167.14 11.64 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.114 0.483 . . . . 0.0 110.424 -177.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.4 mm-40 -66.04 166.06 12.27 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-N 114.226 -1.352 . . . . 0.0 112.52 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.623 ' HE2' ' NE1' ' A' ' 7' ' ' TRP . 20.6 pttt -77.56 -45.87 24.01 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.807 -174.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.623 ' NE1' ' HE2' ' A' ' 6' ' ' LYS . 93.9 m95 -78.33 24.2 0.27 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -83.87 -176.57 6.34 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -73.17 -18.12 61.3 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.4 t 62.5 31.37 17.06 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 122.262 1.03 . . . . 0.0 109.475 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.2 pt -105.46 163.57 4.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.734 -0.603 . . . . 0.0 110.924 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 p -132.09 87.78 42.88 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-O 121.678 0.752 . . . . 0.0 109.687 177.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -68.48 -41.94 5.84 Favored 'Trans proline' 0 CA--C 1.519 -0.245 0 C-N-CA 122.735 2.29 . . . . 0.0 112.276 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 42.4 pt -138.8 166.68 22.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -75.1 145.48 42.23 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.64 14.26 60.02 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -88.96 176.08 7.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -103.0 150.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.814 0.816 . . . . 0.0 111.392 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -115.63 163.65 15.49 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.293 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 59.9 m -66.01 142.29 57.88 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.801 0.334 . . . . 0.0 110.386 -176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -53.59 156.91 4.1 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.04 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -61.55 144.14 97.54 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.772 2.314 . . . . 0.0 111.441 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.63 -3.39 63.11 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.457 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.6 mt -111.83 154.74 24.67 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 2.3 pp -130.43 144.74 37.04 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.757 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.9 t -94.27 99.25 11.52 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.2 -101.04 1.51 Allowed Glycine 0 N--CA 1.437 -1.299 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.292 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.31 -51.89 10.14 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.524 2.816 . . . . 0.0 112.789 -177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -161.43 -38.4 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.4 m -101.74 171.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.462 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 72.2 m -88.78 157.53 18.46 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 174.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.272 -2.799 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 CA--C 1.489 -1.403 0 CA-C-O 121.082 0.468 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -97.05 106.36 18.68 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 174.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.3 p -172.33 176.7 3.29 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.4 pt20 -113.37 152.3 30.17 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -66.31 170.94 5.29 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 124.366 1.041 . . . . 0.0 111.361 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.9 pttt -74.13 -44.66 52.9 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.915 -0.714 . . . . 0.0 112.905 -171.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.537 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 89.8 m95 -81.81 24.95 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -84.21 -176.16 6.13 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -79.37 -3.07 44.59 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.5 t 52.68 59.68 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.383 1.073 . . . . 0.0 111.081 176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.8 mt -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.3 139.53 26.92 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.05 -174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -66.94 -38.49 16.54 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.591 2.194 . . . . 0.0 111.612 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.9 mt -121.43 119.35 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.07 137.06 50.89 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.527 -178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.05 -6.63 37.19 Favored Glycine 0 C--N 1.312 -0.787 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.76 156.4 37.76 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.8 t -112.95 129.53 68.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -120.27 106.53 11.99 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 121.301 0.572 . . . . 0.0 111.27 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 14.4 p -162.75 168.55 21.33 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 173.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.6 m -50.53 150.96 4.34 Favored Pre-proline 0 CA--C 1.557 1.223 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.12 132.03 39.67 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.052 2.501 . . . . 0.0 113.296 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.62 0.81 52.93 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.905 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 6' ' ' LYS . 23.0 mt -109.07 147.88 31.69 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.993 0.425 . . . . 0.0 110.208 -178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 10.3 pt -125.21 130.79 72.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.594 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 13.8 t -97.4 102.33 14.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.07 -75.52 1.01 Allowed Glycine 0 C--N 1.305 -1.175 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.648 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.93 -79.94 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.646 1.564 . . . . 0.0 112.355 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -137.59 -2.15 1.99 Allowed 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' CYS . 33.9 m -140.93 170.76 13.61 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.322 -174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.579 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 95.8 m -90.88 166.03 13.28 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 173.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.293 -1.891 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 . . . . . 0 CA--C 1.487 -1.463 0 CA-C-O 120.732 0.301 . . . . 0.0 110.688 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -91.7 106.49 18.52 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.135 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.4 p -114.16 171.53 7.55 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.442 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -119.22 163.23 17.41 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.75 174.6 4.18 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 14.3 pttt -73.44 -46.11 50.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -172.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.529 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 76.9 m95 -80.67 20.75 0.71 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.056 0.455 . . . . 0.0 111.934 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -85.08 -163.43 0.83 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.447 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -64.66 -26.51 68.42 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . 26.5 t 68.55 -71.21 0.12 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 0.0 110.961 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.35 148.08 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.24 143.87 15.78 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.32 61.61 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.058 2.506 . . . . 0.0 113.498 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 76.0 mt -137.62 122.72 24.52 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.1 pt? -75.08 138.03 41.85 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.752 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.31 31.55 27.75 Favored Glycine 0 N--CA 1.432 -1.585 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.139 -176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -82.91 174.23 11.1 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 122.7 -0.294 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.2 t -103.81 140.9 20.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -107.62 161.72 14.61 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.442 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 43.6 m -65.97 151.77 46.04 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.109 0.481 . . . . 0.0 110.872 -177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -60.2 154.8 49.73 Favored Pre-proline 0 C--N 1.304 -1.375 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.68 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.34 152.73 81.13 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.871 2.381 . . . . 0.0 112.055 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.04 -10.81 58.64 Favored Glycine 0 C--N 1.308 -0.982 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 6' ' ' LYS . 15.9 mt -109.41 156.93 19.44 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -126.26 142.64 42.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.8 t -98.65 99.56 10.69 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.29 -85.83 0.98 Allowed Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.229 -176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -71.24 -88.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 122.04 1.827 . . . . 0.0 112.849 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -119.83 -17.08 8.62 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.73 -0.607 . . . . 0.0 110.292 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 26.6 m -125.86 174.54 9.62 Favored 'Isoleucine or valine' 0 C--O 1.251 1.132 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.961 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 76.4 m -92.52 165.39 13.04 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.175 178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.548 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 . . . . . 0 C--O 1.241 0.617 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -85.28 107.62 17.39 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.407 0.622 . . . . 0.0 109.746 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -154.85 175.0 14.31 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 23.9 pt20 -119.27 157.55 27.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.595 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.74 178.44 5.45 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.1 ptmt -70.85 -49.39 46.72 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.864 -1.062 . . . . 0.0 113.376 -171.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.454 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 90.6 m95 -82.89 24.91 0.71 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -83.22 -169.25 2.44 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -71.26 -26.85 63.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.699 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.21 108.25 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 O-C-N 124.15 0.906 . . . . 0.0 109.164 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 19' ' ' TYR . 37.1 pt -115.15 157.78 15.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.789 -0.569 . . . . 0.0 110.357 -175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.3 m -123.55 92.86 48.33 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-O 121.733 0.778 . . . . 0.0 110.822 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.07 -32.88 83.74 Favored 'Trans proline' 0 C--O 1.224 -0.203 0 C-N-CA 122.643 2.229 . . . . 0.0 110.91 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.461 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 44.4 mm -132.69 142.93 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.15 120.52 14.47 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.101 0.477 . . . . 0.0 109.721 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.05 2.72 59.24 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 82.4 t80 -125.26 114.15 18.57 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.8 131.47 50.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' HB3' HG13 ' A' ' 11' ' ' ILE . 90.6 t80 -94.12 106.3 18.27 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.878 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 93.9 m -159.77 170.67 21.01 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.8 m -62.0 149.18 86.77 Favored Pre-proline 0 C--N 1.295 -1.767 0 O-C-N 123.137 0.273 . . . . 0.0 110.459 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.93 142.19 67.85 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.678 2.252 . . . . 0.0 111.767 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.34 -1.86 56.13 Favored Glycine 0 N--CA 1.432 -1.6 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.409 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.5 mt -109.39 153.55 23.82 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.6 pt -125.37 134.98 65.44 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.803 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.6 t -89.64 87.93 7.21 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.92 -87.84 0.6 Allowed Glycine 0 N--CA 1.438 -1.193 0 CA-C-N 114.777 -1.102 . . . . 0.0 112.766 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.428 2.085 . . . . 0.0 112.707 -178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -134.07 4.36 3.5 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.42 170.57 11.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.513 -174.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 85.6 m -81.91 166.72 19.65 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 174.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.6 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.1 p . . . . . 0 C--N 1.282 -2.367 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -171.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.817 0.342 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -90.75 95.41 10.13 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 175.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 p -118.29 179.42 4.11 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.264 -173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 25.3 pt20 -115.28 158.07 22.88 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -67.51 168.72 10.42 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.627 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.9 ptmt -74.11 -49.64 22.97 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.65 -178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.436 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 83.1 m95 -84.22 30.51 0.53 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -175.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -84.03 -153.2 0.14 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 175.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -96.86 -14.86 21.56 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.758 -0.589 . . . . 0.0 109.845 175.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t 72.86 143.6 0.07 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.255 1.422 . . . . 0.0 111.597 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.8 mt -111.94 132.23 61.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.45 97.22 14.68 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-O 121.56 0.695 . . . . 0.0 111.501 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -64.95 -49.19 3.03 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.739 2.292 . . . . 0.0 110.699 177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.3 pt -136.44 150.95 27.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -66.7 130.65 43.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.75 2.29 55.23 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -111.77 125.75 54.33 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.7 t -105.58 129.65 58.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 123.414 0.446 . . . . 0.0 110.327 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -130.59 105.73 8.03 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.01 0.433 . . . . 0.0 110.936 172.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 57.6 m -163.06 -177.12 5.24 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 174.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.63 153.19 63.53 Favored Pre-proline 0 C--N 1.293 -1.879 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.332 172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.66 138.74 71.45 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 122.538 2.159 . . . . 0.0 112.186 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.16 -11.03 61.97 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.026 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 6' ' ' LYS . 23.3 mt -98.64 157.08 16.48 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 37.3 pt -127.58 129.67 70.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.942 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 15.5 t -86.62 96.16 10.01 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.42 -84.81 1.68 Allowed Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.793 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -67.8 -38.5 13.45 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.167 1.911 . . . . 0.0 112.928 -176.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -174.2 -37.94 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.3 m -107.65 175.1 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.583 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.627 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 66.4 m -90.2 173.8 7.96 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.549 175.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.4 p . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 . . . . . 0 CA--C 1.482 -1.637 0 CA-C-O 120.76 0.314 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.77 136.17 53.17 Favored 'General case' 0 N--CA 1.407 -2.601 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.7 p -139.18 173.31 11.69 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.614 176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -119.65 160.47 22.44 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -66.01 172.62 3.57 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.79 0.805 . . . . 0.0 112.727 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.588 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 12.4 ptmt -69.89 -48.99 56.52 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.172 -176.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.74 21.5 0.83 Allowed 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -84.77 -170.64 3.22 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.8 -9.43 37.13 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.8 t 68.49 -78.63 0.04 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.22 1.008 . . . . 0.0 112.832 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 50.1 mm -96.7 132.05 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.018 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 m -90.63 127.23 53.29 Favored Pre-proline 0 C--N 1.287 -2.147 0 CA-C-O 121.204 0.526 . . . . 0.0 112.069 -175.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.41 -6.6 12.78 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.356 2.037 . . . . 0.0 110.451 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.9 mt -110.22 123.15 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.21 145.96 41.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.69 6.55 40.6 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.462 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -114.43 175.31 5.54 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 122.685 0.394 . . . . 0.0 109.969 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.1 m -110.61 -178.75 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-O 121.808 0.813 . . . . 0.0 112.842 -176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -96.04 164.59 12.64 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.47 -1.241 . . . . 0.0 109.393 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.7 p -65.26 141.56 58.58 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.8 m -41.77 144.46 0.81 Allowed Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.657 1.183 . . . . 0.0 113.761 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.79 138.46 69.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.012 2.474 . . . . 0.0 111.858 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.11 -23.01 17.3 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 6' ' ' LYS . 20.3 mt -91.79 156.51 17.49 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 29.3 pt -125.04 137.38 57.81 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.287 179.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -88.96 100.74 13.43 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.08 -83.2 0.97 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.855 -174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -75.53 -66.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.945 1.764 . . . . 0.0 111.334 -178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -141.3 -26.5 0.7 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.4 m -107.27 172.58 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.154 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.613 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.588 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 75.8 m -92.27 170.88 9.45 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.299 0.571 . . . . 0.0 109.765 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--N 1.285 -2.202 0 C-N-CA 124.957 1.303 . . . . 0.0 107.503 -175.143 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 . . . . . 0 CA--C 1.494 -1.201 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.65 79.48 8.22 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.583 0.706 . . . . 0.0 109.618 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.2 p -143.42 171.7 13.78 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.875 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.522 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 28.4 pt20 -116.14 159.7 21.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -70.34 174.68 5.37 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.511 -176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 19.2 ptmt -72.79 -49.56 29.88 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.408 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 93.8 m95 -82.03 25.74 0.56 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 112.769 -174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -84.06 178.2 7.94 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -63.55 -31.62 72.84 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 123.204 0.315 . . . . 0.0 110.835 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 41.0 t 79.46 143.37 0.08 Allowed 'General case' 0 C--O 1.248 1.014 0 C-N-CA 124.975 1.31 . . . . 0.0 112.392 177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' A' ' 19' ' ' TYR . 67.4 mt -125.1 132.15 71.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.31 99.75 30.39 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 17' ' ' PHE . 35.7 Cg_endo -67.15 -52.97 0.54 Allowed 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.321 2.014 . . . . 0.0 111.841 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 74.7 mt -140.23 141.73 32.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.02 120.64 6.66 Favored 'General case' 0 C--O 1.249 1.078 0 CA-C-O 121.679 0.752 . . . . 0.0 111.725 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.38 -6.46 36.33 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.198 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' O ' ' HD2' ' A' ' 13' ' ' PRO . 98.5 m-85 -126.75 125.97 42.66 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.86 146.56 33.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.436 ' CE2' ' HG3' ' A' ' 13' ' ' PRO . 32.4 m-85 -106.27 105.17 15.08 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-O 121.738 0.78 . . . . 0.0 110.56 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.522 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 77.0 m -162.55 173.31 14.14 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 102.598 -3.112 . . . . 0.0 102.598 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.5 m -59.62 146.39 80.57 Favored Pre-proline 0 C--N 1.288 -2.089 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.453 173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -64.01 138.05 60.48 Favored 'Trans proline' 0 C--O 1.241 0.674 0 C-N-CA 122.875 2.384 . . . . 0.0 111.995 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.18 -14.2 51.77 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.227 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.9 154.42 17.71 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 34.9 pt -120.73 134.66 63.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.693 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 12.1 t -91.84 91.33 7.87 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.39 -88.15 1.6 Allowed Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.039 -171.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.63 -41.29 79.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.246 2.631 . . . . 0.0 112.598 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -178.55 -36.51 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.88 174.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.292 -178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.7 m -83.52 171.76 13.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.514 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.3 p . . . . . 0 C--N 1.298 -1.637 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -172.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 . . . . . 0 CA--C 1.5 -0.976 0 CA-C-O 121.25 0.547 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 3' ' ' CYS . 29.4 t70 -90.5 -135.29 0.12 Allowed 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 174.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.405 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 24.9 p -113.43 175.27 5.52 Favored 'General case' 0 C--N 1.261 -3.279 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -121.1 163.58 18.16 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -71.54 177.05 4.26 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.419 -177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HB3' HD22 ' A' ' 24' ' ' LEU . 19.2 ptmt -72.05 -49.75 34.1 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.409 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.4 m95 -82.76 22.72 0.87 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.171 0.51 . . . . 0.0 112.244 -175.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -85.01 176.22 8.56 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -51.99 -29.62 21.55 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.835 0.854 . . . . 0.0 112.604 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 40.4 t 69.76 -73.67 0.09 Allowed 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.379 1.072 . . . . 0.0 110.387 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 49.3 mm -96.46 131.15 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.132 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 14' ' ' ILE . 12.2 p -135.87 119.4 12.65 Favored Pre-proline 0 N--CA 1.42 -1.959 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.93 19.16 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.023 2.482 . . . . 0.0 114.33 -174.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 12' ' ' VAL . 27.8 pt -99.79 161.96 3.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.8 tp -75.01 122.76 24.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.47 35.75 1.54 Allowed Glycine 0 C--N 1.294 -1.78 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.01 131.93 41.46 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.572 1.149 . . . . 0.0 111.244 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 m -111.14 141.5 26.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.34 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.24 144.64 29.02 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.2 p -80.55 144.72 32.22 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.958 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.3 m -48.18 152.77 1.4 Allowed Pre-proline 0 C--N 1.297 -1.686 0 C-N-CA 124.861 1.264 . . . . 0.0 114.18 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.98 148.9 87.12 Favored 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 123.453 2.769 . . . . 0.0 113.483 -176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.68 -13.4 67.58 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.03 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -95.77 158.7 15.33 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 120.986 0.422 . . . . 0.0 109.91 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 17.9 pt -129.23 134.65 63.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.54 178.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.5 t -92.46 98.38 11.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.34 -84.45 1.51 Allowed Glycine 0 N--CA 1.431 -1.636 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.625 -174.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.12 -82.13 0.01 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 121.946 1.764 . . . . 0.0 112.417 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -125.89 -15.07 6.01 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 174.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.1 m -127.51 176.66 6.97 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.43 -175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 99.7 m -85.68 172.92 10.49 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.644 177.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.289 -2.062 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -171.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 . . . . . 0 C--O 1.24 0.559 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -117.43 100.74 7.87 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -98.64 170.92 8.46 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.2 pt20 -113.68 156.92 22.89 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.7 176.69 1.87 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.2 ptmt -69.59 -49.22 56.11 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.622 -175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 91.0 m95 -81.68 21.59 0.81 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -85.01 -160.99 0.53 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.371 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -66.5 -29.64 69.78 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 123.168 0.587 . . . . 0.0 110.71 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.8 t 71.99 -78.56 0.05 OUTLIER 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.574 1.15 . . . . 0.0 111.474 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.8 mt -103.9 132.54 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.09 124.59 26.46 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.37 -19.12 43.95 Favored 'Trans proline' 0 C--O 1.243 0.733 0 C-N-CA 122.675 2.25 . . . . 0.0 112.919 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.5 pt -110.98 144.38 19.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.816 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.9 mt -82.28 171.96 13.66 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.092 -177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.77 5.01 57.77 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -173.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -126.83 175.04 8.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 124.817 1.247 . . . . 0.0 108.116 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.89 169.0 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -93.22 164.81 13.1 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 123.158 0.583 . . . . 0.0 109.527 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 30.7 p -64.35 150.51 46.09 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.784 -175.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.5 m -50.9 153.17 3.14 Favored Pre-proline 0 C--N 1.307 -1.25 0 C-N-CA 124.832 1.253 . . . . 0.0 112.433 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.32 147.1 77.48 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 122.938 2.425 . . . . 0.0 111.797 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.87 3.57 57.01 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.9 mt -117.12 156.49 27.52 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 44.1 pt -118.77 137.3 53.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 13.8 t -100.31 105.21 16.72 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.23 -84.88 1.63 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.894 -173.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.13 -37.62 82.62 Favored 'Trans proline' 0 C--O 1.239 0.538 0 C-N-CA 123.266 2.644 . . . . 0.0 113.317 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 65.6 t80 178.08 -38.37 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.51 176.41 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 CA-C-N 113.746 -1.57 . . . . 0.0 109.608 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 70.8 m -93.26 173.1 7.89 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.285 -2.229 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -171.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 C--O 1.243 0.745 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.16 109.07 20.42 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 175.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 7.3 p -148.83 179.28 7.96 Favored 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.044 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.6 pt20 -114.98 162.16 17.34 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -64.21 167.92 6.09 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 32' ' ' VAL . 17.8 ptmt -68.1 -48.87 64.3 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.89 -1.505 . . . . 0.0 111.343 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -80.95 23.28 0.56 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -84.86 169.39 14.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.346 176.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -51.43 -44.38 62.28 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.795 1.238 . . . . 0.0 112.481 -173.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.5 t 70.99 -2.53 2.31 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.145 0.978 . . . . 0.0 113.123 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' O ' ' HD3' ' A' ' 13' ' ' PRO . 35.7 pt -96.45 179.43 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.686 -0.634 . . . . 0.0 110.137 -178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.82 92.96 26.91 Favored Pre-proline 0 C--N 1.309 -1.177 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 11' ' ' ILE . 8.2 Cg_exo -77.31 -40.08 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.481 2.12 . . . . 0.0 110.574 177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.3 pt -148.16 164.97 5.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.16 169.95 17.1 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.365 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.31 34.93 69.23 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -87.65 170.48 11.23 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.073 -0.564 . . . . 0.0 110.645 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.7 t -107.55 145.7 14.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -109.67 163.53 13.39 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 29.8 p -73.98 145.17 44.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.689 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.4 m -47.17 153.62 0.88 Allowed Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.07 133.81 34.62 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.204 2.603 . . . . 0.0 111.007 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.85 8.8 38.87 Favored Glycine 0 C--N 1.3 -1.436 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' A' ' 6' ' ' LYS . 29.3 mt -121.1 154.51 36.05 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 28.7 pt -123.13 139.54 49.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.92 178.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -93.5 99.28 11.78 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.54 -86.27 1.93 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.471 -0.786 . . . . 0.0 114.571 -170.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.79 -33.51 84.93 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.162 2.575 . . . . 0.0 113.118 -174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 t80 178.87 -41.82 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -177.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.5 m -106.64 177.5 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 113.617 -1.628 . . . . 0.0 109.134 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 96.5 m -85.06 174.84 9.41 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.6 p . . . . . 0 C--N 1.287 -2.127 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -171.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? . . . . . 0 CA--C 1.496 -1.119 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.46 81.67 8.2 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.132 0.968 . . . . 0.0 111.907 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.0 p -146.27 174.76 11.05 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 106.922 -1.511 . . . . 0.0 106.922 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 26.5 pt20 -105.55 151.73 23.96 Favored 'General case' 0 N--CA 1.423 -1.799 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.201 -175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.05 171.48 6.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 124.674 1.234 . . . . 0.0 112.109 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.1 ptmt -70.63 -49.53 46.6 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.674 -175.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.419 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.1 m95 -79.19 20.84 0.49 Allowed 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -84.11 179.69 7.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -74.1 -6.91 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.326 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.606 ' O ' ' HB ' ' A' ' 18' ' ' VAL . 40.3 t 74.41 -0.91 3.22 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.157 0.983 . . . . 0.0 112.074 172.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.34 132.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.549 -176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.2 m -115.49 169.44 6.84 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.85 35.49 0.26 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 123.258 2.639 . . . . 0.0 114.86 -176.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.4 mt -132.78 125.03 51.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.8 129.39 37.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.82 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.54 -6.77 79.15 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.013 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -127.93 109.77 11.9 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 10' ' ' CYS . 27.7 m -125.1 129.35 73.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -137.33 163.0 32.04 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.231 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 10.0 p -142.43 -175.06 4.31 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 173.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -56.1 152.25 22.67 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 118.079 0.4 . . . . 0.0 111.902 177.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.19 145.92 74.35 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.678 2.252 . . . . 0.0 112.029 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.86 -18.96 55.17 Favored Glycine 0 C--N 1.302 -1.34 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.241 179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.478 HD22 ' HB3' ' A' ' 6' ' ' LYS . 19.8 mt -92.49 160.4 15.08 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.2 pt -129.0 137.27 57.64 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.7 t -86.94 99.72 12.07 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.97 -84.87 1.05 Allowed Glycine 0 N--CA 1.437 -1.287 0 CA-C-N 115.05 -0.977 . . . . 0.0 113.47 -171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.48 -71.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 121.604 1.536 . . . . 0.0 110.864 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -133.04 -20.51 2.17 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.0 m -111.94 171.2 3.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.878 -177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.1 m -85.64 171.35 11.73 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -173.003 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 32.2 mmm180 . . . . . 0 N--CA 1.441 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -92.44 102.3 14.76 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 121.294 0.569 . . . . 0.0 109.885 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.8 p -132.11 166.29 22.12 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.977 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 29.3 pt20 -112.11 159.3 18.64 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -67.61 174.65 3.35 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 123.929 0.768 . . . . 0.0 111.441 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.9 pttt -72.91 -46.72 51.09 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 120.034 -0.666 . . . . 0.0 112.616 -173.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.47 ' HE1' ' HE2' ' A' ' 6' ' ' LYS . 82.6 m95 -81.69 22.59 0.72 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.15 0.5 . . . . 0.0 111.549 -176.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -84.92 -173.62 4.83 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.223 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -63.12 -23.74 67.58 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.1 t 58.22 93.76 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.942 0.877 . . . . 0.0 109.7 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG13 HE22 ' A' ' 4' ' ' GLN . 67.8 mt -96.38 136.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.592 -172.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' A' ' 18' ' ' VAL . 14.1 m -129.67 83.72 63.57 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 112.298 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.462 ' HD2' ' CE1' ' A' ' 19' ' ' TYR . 20.8 Cg_exo -71.6 -43.31 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.306 2.004 . . . . 0.0 110.479 175.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.3 mm -105.21 123.05 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 97.8 mt -67.38 128.9 38.13 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.152 0.501 . . . . 0.0 110.982 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 -6.54 35.53 Favored Glycine 0 N--CA 1.434 -1.487 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.431 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -126.92 134.43 50.44 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 26' ' ' CYS . 21.6 m -106.64 131.22 57.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CE1' ' HD2' ' A' ' 13' ' ' PRO . 71.5 m-85 -103.94 106.06 16.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 122.409 1.1 . . . . 0.0 112.39 -175.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.471 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 20.2 p -163.42 170.97 16.65 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 94.4 m -54.43 148.15 25.6 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.04 146.55 91.14 Favored 'Trans proline' 0 C--O 1.248 0.988 0 C-N-CA 122.825 2.35 . . . . 0.0 112.826 -177.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.44 -13.83 61.16 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 6' ' ' LYS . 17.1 mt -101.44 152.71 20.42 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 22.8 pt -124.36 143.57 37.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 8.1 t -102.49 104.19 14.6 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.97 -91.29 1.24 Allowed Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.286 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.31 -71.2 0.03 OUTLIER 'Trans proline' 0 C--O 1.241 0.66 0 C-N-CA 123.032 2.488 . . . . 0.0 112.815 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -139.09 -25.06 0.87 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.98 171.97 4.7 Favored 'Isoleucine or valine' 0 C--O 1.253 1.255 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.195 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 6' ' ' LYS . 86.2 m -86.5 163.0 17.77 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 121.573 0.701 . . . . 0.0 109.563 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.284 -2.281 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 -179.474 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 . . . . . 0 CA--C 1.487 -1.449 0 CA-C-O 120.944 0.402 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -92.58 106.77 18.69 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.7 p -149.15 172.21 15.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.027 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 12.7 pt20 -113.87 162.48 16.31 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.244 -178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -68.71 178.47 2.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.538 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 18.7 ptmt -77.13 -49.77 14.49 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 114.646 -1.161 . . . . 0.0 112.41 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.439 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 92.0 m95 -82.92 26.54 0.6 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.586 -0.696 . . . . 0.0 112.503 -173.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -83.17 170.63 14.53 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -59.86 -27.66 66.86 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -175.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 29' ' ' PHE . 28.5 t 57.75 41.66 24.77 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.063 0.935 . . . . 0.0 109.964 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -96.02 159.05 3.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -146.06 133.68 10.37 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.545 -176.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.95 -48.34 16.82 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.96 2.44 . . . . 0.0 112.71 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 71.8 mt -118.75 129.55 74.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -69.46 151.61 45.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.729 0.3 . . . . 0.0 110.672 -178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.47 -5.23 54.76 Favored Glycine 0 C--N 1.313 -0.736 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -126.69 148.13 49.88 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.4 130.16 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -132.64 118.25 18.92 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 95.8 m -135.92 178.1 7.31 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 169.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 95.4 m -63.45 146.26 96.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.49 173.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.85 130.56 28.09 Favored 'Trans proline' 0 C--O 1.249 1.045 0 C-N-CA 123.019 2.479 . . . . 0.0 113.039 -175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.72 -12.79 27.49 Favored Glycine 0 N--CA 1.438 -1.226 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 6' ' ' LYS . 22.4 mt -99.06 156.05 17.13 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 30.5 pt -124.25 138.34 54.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.1 t -89.86 97.13 11.01 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.9 -88.35 0.52 Allowed Glycine 0 N--CA 1.43 -1.713 0 CA-C-N 114.726 -1.125 . . . . 0.0 113.146 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -74.93 -75.89 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 121.554 1.502 . . . . 0.0 111.135 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' A' ' 10' ' ' CYS . 74.3 m-85 -130.03 -7.14 4.41 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 174.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.24 168.43 23.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.99 -175.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 74.8 m -83.33 167.76 17.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.452 0.644 . . . . 0.0 110.152 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 7.5 p . . . . . 0 C--N 1.284 -2.267 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 . . . . . 0 C--O 1.246 0.871 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.22 121.7 42.76 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.0 p -65.82 154.56 38.8 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.275 0.56 . . . . 0.0 111.674 -175.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 8.5 pt20 -107.35 158.64 16.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.75 176.92 1.79 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 124.13 0.894 . . . . 0.0 111.156 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.555 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 17.8 ptmt -73.29 -51.07 18.9 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.434 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 86.0 m95 -84.49 30.39 0.55 Allowed 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 112.041 -175.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -83.76 -119.19 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.63 -37.57 5.65 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 43.6 t 69.15 108.85 0.05 Allowed 'General case' 0 C--O 1.245 0.846 0 O-C-N 124.221 0.951 . . . . 0.0 111.164 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.476 HG23 ' HB3' ' A' ' 19' ' ' TYR . 10.1 tt -110.84 138.54 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -115.99 90.49 28.22 Favored Pre-proline 0 CA--C 1.554 1.12 0 CA-C-O 121.4 0.619 . . . . 0.0 110.426 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.61 -41.12 11.95 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.632 2.221 . . . . 0.0 111.897 -177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 17' ' ' PHE . 47.4 mm -123.54 129.55 74.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.38 120.68 12.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.588 0.709 . . . . 0.0 110.851 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.61 -6.05 44.54 Favored Glycine 0 N--CA 1.436 -1.322 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.879 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 14' ' ' ILE . 88.5 t80 -126.74 113.47 16.7 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.05 142.17 18.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.476 ' HB3' HG23 ' A' ' 11' ' ' ILE . 68.2 t80 -102.61 106.46 17.14 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.825 0.821 . . . . 0.0 112.013 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 85.7 m -150.21 177.74 9.64 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 175.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 88.1 m -61.76 149.5 84.81 Favored Pre-proline 0 C--N 1.291 -1.95 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.996 174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.4 138.52 71.58 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.913 2.408 . . . . 0.0 112.569 -176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.27 -2.9 50.73 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.555 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 6' ' ' LYS . 24.8 mt -107.63 157.23 18.24 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 21.0 pt -132.97 145.18 34.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 6.5 t -95.65 99.32 11.19 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -177.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.98 -87.38 1.32 Allowed Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.362 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.69 -49.51 3.1 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.562 2.175 . . . . 0.0 113.39 -176.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -162.45 -32.52 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.0 m -119.61 176.59 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.638 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 26' ' ' CYS . 87.0 m -75.77 172.53 12.5 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 123.781 0.676 . . . . 0.0 110.98 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 8.0 p . . . . . 0 C--N 1.29 -2.003 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -171.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 . . . . . 0 N--CA 1.445 -0.692 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -104.61 106.68 17.27 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.2 p -121.48 169.1 10.98 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.744 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.475 ' HG2' ' HA ' ' A' ' 20' ' ' CYS . 27.7 pt20 -114.92 158.37 22.09 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.215 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' HB2' ' HG2' ' A' ' 8' ' ' GLU . 35.8 mt-10 -66.55 174.5 2.76 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.681 -177.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' A' ' 31' ' ' CYS . 19.6 ptmt -69.95 -49.95 46.75 Favored 'General case' 0 C--O 1.208 -1.105 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.28 -176.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.41 ' CD1' ' HG3' ' A' ' 6' ' ' LYS . 89.2 m95 -83.8 25.08 0.82 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.566 -0.709 . . . . 0.0 112.505 -175.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 5' ' ' GLU . 55.4 mm-40 -83.94 175.18 9.75 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.544 177.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -60.4 -32.72 71.59 Favored 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.666 0.604 . . . . 0.0 112.597 -175.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.3 t 62.33 21.16 12.34 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.002 0.906 . . . . 0.0 110.305 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 32.2 pt -96.31 132.33 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-O 121.369 0.604 . . . . 0.0 110.292 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.04 157.52 71.22 Favored Pre-proline 0 C--N 1.293 -1.864 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.46 6.3 5.5 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.756 2.304 . . . . 0.0 113.163 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 13.9 pt -124.73 119.16 55.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -93.2 141.68 28.16 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.6 -173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.2 51.28 Favored Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -119.06 132.7 56.05 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.4 m -104.83 139.21 26.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -136.1 107.63 6.94 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.871 0.367 . . . . 0.0 111.864 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 4' ' ' GLN . 92.0 m -154.15 -178.75 7.32 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.1 m -61.12 146.24 88.48 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-O 120.688 0.28 . . . . 0.0 111.264 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.2 129.41 21.59 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.803 2.335 . . . . 0.0 112.47 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.36 -2.42 26.58 Favored Glycine 0 C--N 1.306 -1.084 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.562 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.0 mt -107.49 160.88 15.32 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 31.0 pt -124.72 132.98 70.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 11.9 t -91.52 87.66 6.47 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.94 -81.24 0.77 Allowed Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 114.063 -1.426 . . . . 0.0 112.967 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.94 -82.39 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.751 2.301 . . . . 0.0 112.291 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -138.29 0.16 2.08 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.23 172.72 15.48 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.492 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 96.8 m -87.06 175.07 8.28 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.553 0.533 . . . . 0.0 110.713 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.257 1.468 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -172.445 . . . . . . . . 0 0 . 1 stop_ save_